← The Wire
SRRKNasdaq
Scholar Rock Holding Corp
Biological Products, (No Diagnostic Substances) · DE · CIK 1727196
Develops novel antibodies targeting growth factors for rare neuromuscular diseases
$5.29B
Market cap
$54.96
Last close
+0.4%
1D
+11.7%
5D
2.1M
Volume
Price · last 39 sessions+18.2%
May 4L $43.80 · H $54.96Jun 29
180
Total filings
Jun 5, 2026
Last filing
12/31
Fiscal year end
SC 13GSCHEDULE 13GFeb 14, 2024SC 13GSC 13GJan 26, 2024SC 13GSC 13GJul 8, 2022SC 13GSC 13GFeb 2, 2021SC 13GSC 13GNov 10, 2020SC 13GSCHEDULE 13GFeb 14, 2019SC 13GSC 13GFeb 14, 2019SC 13GARCH VENTURE FUND VIII, L.P. - SCHOLAR ROCK HOLDING CORP -- SCHEDULE 13GFeb 14, 2019SC 13GSC 13GFeb 14, 2019SC 13GSC 13GJan 7, 2019SC 13GSC 13GJun 11, 2018SC 13GSC 13GJun 8, 2018SC 13GSC 13GJun 4, 2018
Insider Activity
In the 90 days to Feb 23, 2026: 9 sold $15.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 7,427 | $46.94 | $349K |
| Feb 23, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 857 | $47.86 | $41K |
| Feb 23, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 200 | $48.48 | $10K |
| Feb 17, 2026 | Ho JunlinGENERAL COUNSEL | Sell | 9,580 | $46.53 | $446K |
| Feb 17, 2026 | Parlavecchio CarynCHRO | Sell | 9,035 | $46.53 | $420K |
| Feb 17, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 7,989 | $46.53 | $372K |
| Feb 17, 2026 | Marantz Jing L.CHIEF MEDICAL OFFICER | Sell | 4,157 | $46.53 | $193K |
| Jan 22, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 12,779 | $46.85 | $599K |
| Jan 22, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 2,119 | $45.87 | $97K |
| Jan 16, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 8,406 | $44.48 | $374K |
| Jan 16, 2026 | Ho JunlinGENERAL COUNSEL | Sell | 8,016 | $44.48 | $357K |
| Jan 16, 2026 | Parlavecchio CarynCHRO | Sell | 6,600 | $44.48 | $294K |
| Jan 16, 2026 | Marantz Jing L.CHIEF MEDICAL OFFICER | Sell | 5,798 | $44.48 | $258K |
| Jan 14, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 13,112 | $45.20 | $593K |
| Jan 13, 2026 | Hallal DavidChief Executive Officer | Sell | 57,450 | $42.70 | $2.5M |
| Jan 13, 2026 | Vaishnaw AkshayPresident of R&D | Sell | 20,438 | $42.70 | $873K |
| Jan 13, 2026 | Sinha VikasChief Financial Officer | Sell | 16,755 | $42.70 | $715K |
| Jan 13, 2026 | Woods KeithChief Operating Officer | Sell | 16,746 | $42.70 | $715K |
| Dec 16, 2025 | Peng KatieDirector | Sell | 726 | $43.88 | $32K |
| Dec 16, 2025 | Peng KatieDirector | Sell | 280 | $44.63 | $12K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance